CINECA IRIS Institutional Research Information System

NATALI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.248
AS - Asia 9.761
EU - Europa 8.010
SA - Sud America 1.718
AF - Africa 355
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 4
Totale 37.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.727
SG - Singapore 3.078
CN - Cina 2.504
FI - Finlandia 2.141
HK - Hong Kong 1.800
IT - Italia 1.675
BR - Brasile 1.418
SE - Svezia 937
VN - Vietnam 909
BG - Bulgaria 674
DE - Germania 561
GB - Regno Unito 457
FR - Francia 420
TR - Turchia 391
CA - Canada 364
RU - Federazione Russa 327
UA - Ucraina 236
JP - Giappone 161
IN - India 159
KR - Corea 159
SM - San Marino 139
BD - Bangladesh 118
AR - Argentina 114
IE - Irlanda 93
IQ - Iraq 88
MX - Messico 80
CH - Svizzera 79
CI - Costa d'Avorio 75
ZA - Sudafrica 52
AT - Austria 50
EC - Ecuador 49
UZ - Uzbekistan 48
ID - Indonesia 47
SN - Senegal 47
PK - Pakistan 46
SA - Arabia Saudita 43
ES - Italia 40
KE - Kenya 40
MA - Marocco 38
VE - Venezuela 37
NL - Olanda 34
PL - Polonia 34
CO - Colombia 30
AU - Australia 28
BE - Belgio 26
PY - Paraguay 23
CL - Cile 22
AE - Emirati Arabi Uniti 21
NG - Nigeria 21
EG - Egitto 20
JO - Giordania 18
TN - Tunisia 18
CZ - Repubblica Ceca 17
TT - Trinidad e Tobago 17
TW - Taiwan 17
NP - Nepal 16
IR - Iran 14
DZ - Algeria 13
AL - Albania 12
IL - Israele 12
PH - Filippine 12
DO - Repubblica Dominicana 11
LB - Libano 11
MY - Malesia 11
PT - Portogallo 11
PE - Perù 10
PS - Palestinian Territory 10
UY - Uruguay 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
HN - Honduras 8
LT - Lituania 8
CR - Costa Rica 7
JM - Giamaica 7
OM - Oman 7
PA - Panama 7
MN - Mongolia 6
RO - Romania 6
BJ - Benin 5
BO - Bolivia 5
ET - Etiopia 5
GR - Grecia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SV - El Salvador 5
TH - Thailandia 5
AM - Armenia 4
DK - Danimarca 4
GE - Georgia 4
KW - Kuwait 4
NI - Nicaragua 4
BB - Barbados 3
BH - Bahrain 3
EU - Europa 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 37.079
Salva come PNG Salva come JPEG
Città #
Helsinki 1.906
Ashburn 1.902
Singapore 1.788
Hong Kong 1.782
Fairfield 1.657
Woodbridge 1.362
Houston 1.011
Santa Clara 966
Ann Arbor 904
Chandler 846
San Jose 774
Dallas 689
Sofia 671
Seattle 654
Shanghai 631
Wilmington 550
Beijing 527
Cambridge 527
Milan 512
New York 419
Princeton 327
Boardman 325
Ottawa 274
Jacksonville 268
Lawrence 260
Izmir 246
Medford 237
Los Angeles 235
Ho Chi Minh City 223
Lauterbourg 215
Hefei 191
Serra 187
Nanjing 164
Seoul 154
Tokyo 143
Hanoi 138
Des Moines 114
São Paulo 110
Istanbul 104
London 104
Florence 103
Paris 103
Redondo Beach 103
Buffalo 99
Pisa 95
San Diego 93
Dearborn 80
Dong Ket 80
Nanchang 78
Abidjan 75
Council Bluffs 74
Frankfurt am Main 71
Bern 70
Lancaster 68
Munich 65
Dakar 47
Rio de Janeiro 47
Kunming 41
Ogden 41
Changsha 40
Falls Church 40
The Dalles 40
Jüchen 39
Redwood City 39
Tashkent 38
Nairobi 36
Nuremberg 36
San Francisco 36
Shenyang 36
Chicago 35
Da Nang 35
Hebei 35
Rome 35
Baghdad 34
Columbus 33
Tianjin 33
Turku 33
Haiphong 32
Belo Horizonte 31
Dhaka 31
Curitiba 30
Vienna 30
Brasília 29
Warsaw 29
Lucca 28
Jiaxing 27
Johannesburg 27
Washington 27
Fuzhou 26
Hangzhou 26
Düsseldorf 25
Norwalk 25
Toronto 25
Boulder 24
Orem 23
Brussels 22
Orange 22
Guangzhou 21
Phoenix 21
Porto Alegre 21
Totale 26.785
Salva come PNG Salva come JPEG
Nome #
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 2.034
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 501
Hypertension: a metabolic disorder? 278
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 239
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy 220
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 212
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial. 211
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 209
Insulin resistance, adipose depots and gut: Interactions and pathological implications 207
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 195
Diabetes and high blood pressure 193
Effects of insulin on the kidney and the cardiovascular system 189
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 188
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 187
Insulin: new roles for an ancient hormone 182
Effect of insulin on skeletal muscle metabolism in essential hypertension 179
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 176
Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals 176
Beta-cell function in obesity: effects of weight loss 174
Hypertension, insulin resistance, and diabetes 172
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 171
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene 171
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex 170
Effect of acute hyperglycemia on insulin secretion in humans 169
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data 168
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 167
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 167
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 166
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 166
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 166
Endothelial dysfunction in type 2 diabetes 163
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database 161
Early metabolic markers of the development of dysglycaemia and type 2 diabetes and their physiological significance 161
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study 161
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 159
Cardiovascular organ damage in type 2 diabetes mellitus: The role of lipids and inflammation 159
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 158
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 157
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 157
Insulino Resistenza e Flusso Ematico: Studi con L'Adenosina in Pazienti con Ipertensione Essenziale 156
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 156
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. 155
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state 154
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: A European cross-sectional study 154
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions 154
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 153
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 153
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 153
Effect of insulin on skeletal muscle metabolism in essential hypertension 152
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes 152
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 151
Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association? 150
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study 149
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 148
A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance 146
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance 145
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality 145
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 145
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. 142
Reciprocal association between insulin sensitivity and the haematocrit in man 142
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study 140
Impaired insulin action on skeletal muscle metabolism in essential hypertension 140
Autonomic and hemodynamic responses to insulin in lean and obese humans 139
A novel fasting blood test for insulin resistance and prediabetes 139
Influence of endogenous NEFA on beta cell function in humans 139
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy RID F-2315-2010 138
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. 138
Association of fasting glucagon and proinsulin concentrations with insulin resistance 137
Insulin sensitivity and fasting insulin: association with indicators of cardiovascular disease in healthy subjects. The RISC Study 136
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes 136
Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp 136
Effects of angiotensin-converting enzyme inhibition on carbohydrate metabolism and insulin sensitivity in hypertensive patients 135
Insulin resistance, insulin response, and obesity as indicators of metabolic risk 135
Renovascular hypertension and insulin sensitivity 133
Insulin resistance of stress: Sites and mechanisms 133
Insulin-resistance and triglycerides as independent predictors of the early macrovascular involvement in type 2 diabetic patients 132
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia 132
A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants 132
Effects of Mild Acute Hypertriglyceridemia on Fasting and Post-Load Glucose Homeostasis 132
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 131
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 130
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 130
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents 130
EFFECTS OF INSULIN ON HEMODYNAMICS AND METABOLISM IN HUMAN FOREARM 129
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of levothyroxine 129
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides 129
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension 129
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study 128
Modulation of postprandial glycemic responses by noncarbohydrate nutrients provides novel approaches to the prevention and treatment of type 2 diabetes 128
Increased gluconeogenesis in NIDDM: Substrate contribution and modulation by lipolysis 127
LDL resistance to copper-induced oxidation: Effect of LDL lipid composition 127
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. 127
A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects 127
Coronary atherosclerosis in non-insulin-dependent diabetes (NIDDM): Risk factors (RF) and impact on mortality. 126
Insulin decreases circulating vitamin E levels in humans 126
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective 126
EFFECT OF INSULIN ON URIC-ACID EXCRETION IN HUMANS 125
Hypertension, insulin resistance, and the metabolic syndrome 124
INVIVO EFFECT OF INSULIN ON INTRACELLULAR CALCIUM LEVELS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 123
Is hyperglycemia a cardiovascular risk factor? 123
Totale 17.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 0 0 0 0 0 128 322
2021/20222.890 43 145 115 224 534 392 63 171 132 52 150 869
2022/20232.759 400 317 178 201 303 359 23 219 482 32 208 37
2023/20242.458 270 273 334 182 375 421 82 71 46 42 85 277
2024/20258.028 52 331 76 326 635 952 610 484 913 1.107 831 1.711
2025/202610.537 731 1.195 1.075 958 860 906 1.133 472 2.362 832 13 0
Totale 37.718